RBC parameter values for different mouse strains and treatments used in the study
| Mouse strain . | RBC (106/μL) . | Hb (g/dL) . | HCT% . | MCV (fL) . | MCH (pg) . | MCHC (g/dL) . | RDW-CV % . | RET count (103/μL) . | RET% . |
|---|---|---|---|---|---|---|---|---|---|
| WT transplanted (HSC-WT → WT recipients) n = 7 | 9.1 ± 0.2∗ | 13.1 ± 0.3∗ | 43.2 ± 1.0∗,† | 47.7 ± 0.9∗,†,‡ | 14.4 ± 0.2∗,†,‡ | 30.2 ± 0.4∗ | 14.8 ± 0.3∗,†,‡ | 443.1 ± 40.4∗ | 4.8 ± 0.4∗,† |
| Hba-a1Fl/Fl/Hba-a2KO/KO, n = 15 | 10.9 ± 0.1§ | 14.3 ± 0.3§ | 46.85 ± 0.9§ | 43.2 ± 0.8 | 13.1 ± 0.2 | 30.5 ± 0.2 | 19.9 ± 0.8§ | 505.2 ± 25.5 | 4.7 ± 0.2§ |
| Hba-a1KO/+/Hba-a2KO/+, n = 9 | 9.0 ± 0.4§ | 11.4 ± 0.5§ | 35.99 ± 1.6†,§ | 40.2 ± 1.1† | 12.8 ± 0.2† | 31.8 ± 0.5 | 31.0 ± 1.2†,§,|| | 605.0 ± 37.4 | 6.8 ± 0.5†,§ |
| HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117 (Hba-a1cKO/cKO/Hba-a2KO/KO) → WT recipients (AG-KO), n = 8 | 13.0 ± 0.4∗,¶ | 14.7 ± 0.3∗,¶ | 68.2 ± 1.3∗,¶ | 52.8 ± 1.4∗,¶ | 11.4 ± 0.3∗,# | 21.6 ± 0.2∗,¶ | 39.0 ± 0.7∗,¶ | 2796.2 ± 114.6∗,¶ | 21.7 ± 1.0∗,¶ |
| FLC Hba-a1KO/KO/Hba-a2KO/KO → WT recipients (AG-FKO), n = 5 | 12.6 ± 0.6 | 15.9 ± 0.7 | 75.34 ± 4.1 | 60.0 ± 2.6 | 12.6 ± 0.2# | 21.1 ± 0.6 | 43.7 ± 1.4 | 2620.9 ± 160.7 | 21.0 ± 1.5 |
| HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117 + ALS20αI (Hba-a1cKO/cKO/Hba-a2KO/KO + ALS20αI) → WT recipients (AG-KOALS20αI), n = 7 | 10.0 ± 0.5¶ | 12.0 ± 0.4¶ | 38.6 ± 1.6¶ | 38.7 ± 0.6‡,¶ | 12.1 ± 0.2‡ | 31.2 ± 0.5¶ | 24.4 ± 0.7‡,||,¶ | 745.9 ± 76.5‡,¶ | 7.4 ± 0.1‡,¶ |
| Mouse strain . | RBC (106/μL) . | Hb (g/dL) . | HCT% . | MCV (fL) . | MCH (pg) . | MCHC (g/dL) . | RDW-CV % . | RET count (103/μL) . | RET% . |
|---|---|---|---|---|---|---|---|---|---|
| WT transplanted (HSC-WT → WT recipients) n = 7 | 9.1 ± 0.2∗ | 13.1 ± 0.3∗ | 43.2 ± 1.0∗,† | 47.7 ± 0.9∗,†,‡ | 14.4 ± 0.2∗,†,‡ | 30.2 ± 0.4∗ | 14.8 ± 0.3∗,†,‡ | 443.1 ± 40.4∗ | 4.8 ± 0.4∗,† |
| Hba-a1Fl/Fl/Hba-a2KO/KO, n = 15 | 10.9 ± 0.1§ | 14.3 ± 0.3§ | 46.85 ± 0.9§ | 43.2 ± 0.8 | 13.1 ± 0.2 | 30.5 ± 0.2 | 19.9 ± 0.8§ | 505.2 ± 25.5 | 4.7 ± 0.2§ |
| Hba-a1KO/+/Hba-a2KO/+, n = 9 | 9.0 ± 0.4§ | 11.4 ± 0.5§ | 35.99 ± 1.6†,§ | 40.2 ± 1.1† | 12.8 ± 0.2† | 31.8 ± 0.5 | 31.0 ± 1.2†,§,|| | 605.0 ± 37.4 | 6.8 ± 0.5†,§ |
| HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117 (Hba-a1cKO/cKO/Hba-a2KO/KO) → WT recipients (AG-KO), n = 8 | 13.0 ± 0.4∗,¶ | 14.7 ± 0.3∗,¶ | 68.2 ± 1.3∗,¶ | 52.8 ± 1.4∗,¶ | 11.4 ± 0.3∗,# | 21.6 ± 0.2∗,¶ | 39.0 ± 0.7∗,¶ | 2796.2 ± 114.6∗,¶ | 21.7 ± 1.0∗,¶ |
| FLC Hba-a1KO/KO/Hba-a2KO/KO → WT recipients (AG-FKO), n = 5 | 12.6 ± 0.6 | 15.9 ± 0.7 | 75.34 ± 4.1 | 60.0 ± 2.6 | 12.6 ± 0.2# | 21.1 ± 0.6 | 43.7 ± 1.4 | 2620.9 ± 160.7 | 21.0 ± 1.5 |
| HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117 + ALS20αI (Hba-a1cKO/cKO/Hba-a2KO/KO + ALS20αI) → WT recipients (AG-KOALS20αI), n = 7 | 10.0 ± 0.5¶ | 12.0 ± 0.4¶ | 38.6 ± 1.6¶ | 38.7 ± 0.6‡,¶ | 12.1 ± 0.2‡ | 31.2 ± 0.5¶ | 24.4 ± 0.7‡,||,¶ | 745.9 ± 76.5‡,¶ | 7.4 ± 0.1‡,¶ |
Mean values are listed with the standard error of the mean. Symbols by values indicate significance (P ≤ .5) between 2 cohorts for that parameter, with comparisons made as indicated in the table legend. Significant differences were determined using a Brown-Forsythe and Welch analysis of variance with Dunnett T3 multiple comparisons test. Male and female AG-KOALS20αI mice were compared for each parameter, and no significant differences were found. Statistical analyses were then performed on samples pooled from male and female animals. “→” indicates HSC transplants using cells from the donor mice into recipient mice. Differences between the heterozygous Hba-a1KO/+/Hba-a2KO/+ constitutive KO animals and homozygous Hba-a1cKO/cKO/Hba-a2KO/KO are likely due to differential levels of α-globin expression from different α-globin genes, a known effect in humans. HBA2 and its ortholog Hba-a1 are expressed at higher levels than HBA1 and Hba-a2.39-41Hba-a1 is analogous to HBA2 in humans, which is 5′ of HBA1, and appears to be dominantly expressed. Therefore, because Hba-a1KO/+/Hba-a2KO/+ mice are missing 1 Hba-a1 and 1 Hba-a2, it is reasonable to predict that they would have a more severe phenotype than Hba-a1cKO/cKO/Hba-a2KO/KO mice that are missing 2 Hba-a2 genes.
Hb, hemoglobin; HCT, hematocrit; MCH, mean corpuscular Hb; MCHC, mean corpuscular Hb concentration; MCV, mean corpuscular volume; RBC, red blood cells; RDW-CV, coefficient of variation in red cell distribution width; RET, reticulocyte; RET%, percentage of reticulocytes.
Comparison between groups 1 and 4 (WT and AG-KO)
Comparison between groups 1 and 3 (WT and Hba-a1ko/+/Hba-a2ko/+)
Comparison between groups 6 and 1 (AG-KOALS20αI and WT)
Comparison between groups 2 and 3 (Hba-a1Fl/Fl/Hba-a2ko/KO and Hba-a1ko/+/Hba-a2ko/+)
Comparison between groups 6 and 3 (AG-KOALS20αI and Hba-a1ko/+/Hba-a2ko/+)
Comparison between groups 6 and 4 (AG-KOALS20αI and AG-KO)
Comparison between groups 4 and 5 (AG-KO and AG-FKO), no differences were observed.